The economic burden of asthma in Canada

Project number: 
13-082
Approval date: 
Monday, January 1, 1900
Principal Investigator: 
Fitzgerald,J. Mark
Institution: 
University of British Columbia (UBC)
Funding Agency: 
GlaxoSmithKline Inc
Datasets requested: 
Not available
Research objective: 

Primary objectives:
1) To estimate the direct and indirect costs of asthma in British Columbia (BC), and the
impact of asthma on quality of life;
2) To estimate the burden of asthma by levels of severity and control;
3) To extrapolate the data and develop a province-wide and Canada-wide burden of
asthma estimate.

Secondary objectives:
1) To examine the determinants of healthcare resource utilization and quality of life in
patients with asthma;
2) To examine the impact of asthma on work productivity (absenteeism and presenteeism);
3) Comparing the retrospective versus prospective calculation of direct asthma costs;
4) Developing an algorithm for assigning levels of severity and control based on
administrative data;
5) To predict the direct and indirect cost of asthma for the next 10 years.

Hypotheses:
- Asthma is associated with a significant burden, in terms of direct and indirect costs, and quality-of-life in Canadians;
- The burden of asthma is adversely correlated with level of control;
- Without significant changes in the management of asthma, the burden of asthma in future will increase.


Page last revised: December 5, 2017